Aehr Test Systems specializes in stress-testing semiconductors to reduce the number of defective chips leaving factories. Aehr is seeing increased interest from hyperscalers and has announced some high-profile orders in recent months.

Aehr Test Systems (AEHR) stock price & volume — 10-year historical chart
Investment Thesis • Updated 2026Q3
the company's inability to maintain positive free cash flow, evidenced by a -28.4% FCF margin in 2026Q3, suggests significant execution risk until the Silicon Carbide market cycle recovers.
Aehr Test Systems (AEHR) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Aehr Test Systems (AEHR) EPS & revenue vs analyst estimates — last 4 quarters
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Apr 7, 2026 | $0.05vs $0.07+28.6% | $10Mvs $11M-5.0% |
| Q1 2026 | Jan 8, 2026 | $0.04vs $0.08+50.0% | $10Mvs $12M-14.5% |
| Q4 2025 | Oct 6, 2025 | $0.01vs $0.01+0.0% | $11Mvs $11M-1.3% |
| Q3 2025 | Jul 8, 2025 | $0.01vs $0.01+33.3% | $14Mvs $15M-5.0% |
Recent stock market news and headlines for Aehr Test Systems (AEHR)
Aehr Test Systems specializes in stress-testing semiconductors to reduce the number of defective chips leaving factories. Aehr is seeing increased interest from hyperscalers and has announced some high-profile orders in recent months.

The now mid-cap semiconductor industry stock Aehr Test Systems NASDAQ: AEHR has continued to trudge higher and higher in 2026. On the year, shares of this semiconductor testing equipment company are up more than 400%.

The now mid-cap semiconductor industry stock Aehr Test Systems NASDAQ: AEHR has continued to trudge higher and higher in 2026. On the year, shares of this semiconductor testing equipment company are up more than 400%.

Aehr Test Systems received a follow-on order for a fully loaded FOX-XP wafer burn-in system from a major silicon photonics customer. This is at least the sixth full-system order Aehr has announced since mid-February.

FREMONT, CA / ACCESS Newswire / June 17, 2026 / Aehr Test Systems (NASDAQ:AEHR), a leading provider of test and burn-in solutions for semiconductor devices used in artificial intelligence (AI), silicon photonics, data center, automotive, and industrial applications, today announced it has received a follow-on production order for a fully automated FOX-XP™ wafer-level burn-in (WLBI) system. The system is configured to test nine wafers in parallel, and includes a fully integrated WaferPak™ Auto Aligner, and a full set of FOX WaferPak Contactors.

Key metrics vs top competitors for Aehr Test Systems (AEHR)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $72.33 | $2.27B | -556.35 | -10.95% | -6.63% | -3.34% | — | |
| $58.70 | $2.76B | -36.92 | 12.74% | -11.54% | -6.84% | — | |
| $139.97 | $4.3B | 36.83 | -17.57% | 11.93% | 9.79% | — | |
| $303.86 | $15.12B | 109.30 | 1.82% | 10.33% | 5.19% | — | |
| $95.67 | $3.32B | -62.12 | 11.61% | -5.28% | -7.5% | — | |
| $118.67 | $9.25B | 171.99 | 2.8% | 8.14% | 6.68% | — |
Aehr Test Systems (AEHR) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Aehr Test Systems (AEHR) SEC filings — annual & quarterly reports (10-K, 10-Q)
Apr 20, 2026·SEC
Apr 8, 2026·SEC
Apr 7, 2026·SEC
Jul 28, 2025·SEC
Get notified when AEHR posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Aehr Test Systems (AEHR) stock FAQ — growth, dividends, profitability & financials explained
Aehr Test Systems (AEHR) reported $45.3M in revenue for fiscal year 2025. This represents a 8% increase from $42.0M in 1997.
Aehr Test Systems (AEHR) saw revenue decline by 10.9% over the past year.
Aehr Test Systems (AEHR) reported a net loss of $11.4M for fiscal year 2025.
Aehr Test Systems (AEHR) has a return on equity (ROE) of -3.3%. Negative ROE indicates the company is unprofitable.
Aehr Test Systems (AEHR) had negative free cash flow of $11.6M in fiscal year 2025, likely due to heavy capital investments.